[1]
Ameen, Z.A. and Ali, S.H. 2018. Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) among Patients with or without Cardiovascular Events. Iraqi Journal of Pharmaceutical Sciences. 27, 2 (Dec. 2018), 150–158. DOI:https://doi.org/10.31351/vol27iss2pp150-158.